BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 9031611)

  • 1. Epstein-Barr virus-associated persistent polyclonal B-cell lymphocytosis with a distinct 69-base pair deletion in the LMP1 oncogene.
    Larcher C; McQuain C; Berger C; Mitterer M; Quesenberry PJ; Huemer HP; Knecht H
    Ann Hematol; 1997 Jan; 74(1):23-8. PubMed ID: 9031611
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Functional analysis of the mutated Epstein-Barr virus oncoprotein LMP1(69del): implications for a new role of naturally occurring LMP1 variants.
    Larcher C; Bernhard D; Schaadt E; Adler B; Ausserlechner MJ; Mitterer M; Huemer HP
    Haematologica; 2003 Dec; 88(12):1324-35. PubMed ID: 14687985
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular analysis of latent membrane protein 1 in patients with Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis in Japan.
    Tabata YHibi S; Teramura T; Kuriyama K; Yagi T; Todo S; Sawada T; Imashuku S
    Leuk Lymphoma; 2000 Jul; 38(3-4):373-80. PubMed ID: 10830744
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of Epstein-Barr virus and soluble CD21 in persistent polyclonal B-cell lymphocytosis.
    Larcher C; Fend F; Mitterer M; Prang N; Schwarzmann F; Huemer HP
    Br J Haematol; 1995 Jul; 90(3):532-40. PubMed ID: 7646990
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chronic active Epstein-Barr virus disease in a case of persistent polyclonal B-cell lymphocytosis.
    Mitterer M; Pescosta N; Fend F; Larcher C; Prang N; Schwarzmann F; Coser P; Huemer HP
    Br J Haematol; 1995 Jul; 90(3):526-31. PubMed ID: 7646989
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epstein-Barr virus latent membrane protein-1 oncogene deletion in post-transplantation lymphoproliferative disorders.
    Scheinfeld AG; Nador RG; Cesarman E; Chadburn A; Knowles DM
    Am J Pathol; 1997 Sep; 151(3):805-12. PubMed ID: 9284829
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sequence polymorphisms between latent membrane proteins LMP1 and LMP2A do not correlate in EBV-associated reactive and malignant lympho-proliferations.
    Berger C; Rothenberger S; Bachmann E; McQuain C; Nadal D; Knecht H
    Int J Cancer; 1999 May; 81(3):371-5. PubMed ID: 10209951
    [TBL] [Abstract][Full Text] [Related]  

  • 8. c-Myc Represses Transcription of Epstein-Barr Virus Latent Membrane Protein 1 Early after Primary B Cell Infection.
    Price AM; Messinger JE; Luftig MA
    J Virol; 2018 Jan; 92(2):. PubMed ID: 29118124
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of the LMP1 oncoprotein in the EBV negative Hodgkin's disease cell line L-428 is associated with Reed-Sternberg cell morphology.
    Knecht H; McQuain C; Martin J; Rothenberger S; Drexler HG; Berger C; Bachmann E; Kittler EL; Odermatt BF; Quesenberry PJ
    Oncogene; 1996 Sep; 13(5):947-53. PubMed ID: 8806684
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epstein-Barr virus-encoded LMP2A regulates viral and cellular gene expression by modulation of the NF-kappaB transcription factor pathway.
    Stewart S; Dawson CW; Takada K; Curnow J; Moody CA; Sixbey JW; Young LS
    Proc Natl Acad Sci U S A; 2004 Nov; 101(44):15730-5. PubMed ID: 15498875
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Epstein-Barr Virus LMP1 oncogene variants in cell lines of different origin].
    Yakovleva LS; Senyuta NB; Goncharova EV; Scherback LN; Smirnova RV; Pavlish OA; Gurtsevitch VE
    Mol Biol (Mosk); 2015; 49(5):800-10. PubMed ID: 26510598
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nucleotide sequences and functions of the Epstein-Barr virus latent membrane protein 1 genes isolated from salivary gland lymphoepithelial carcinomas.
    Jen KY; Higuchi M; Cheng J; Li J; Wu LY; Li YF; Lin HL; Chen Z; Gurtsevitch V; Fujii M; Saku T
    Virus Genes; 2005 Mar; 30(2):223-35. PubMed ID: 15744579
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The 30-base-pair deletion in Chinese variants of the Epstein-Barr virus LMP1 gene is not the major effector of functional differences between variant LMP1 genes in human lymphocytes.
    Johnson RJ; Stack M; Hazlewood SA; Jones M; Blackmore CG; Hu LF; Rowe M
    J Virol; 1998 May; 72(5):4038-48. PubMed ID: 9557692
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regulation of DNA Damage Signaling and Cell Death Responses by Epstein-Barr Virus Latent Membrane Protein 1 (LMP1) and LMP2A in Nasopharyngeal Carcinoma Cells.
    Wasil LR; Wei L; Chang C; Lan L; Shair KH
    J Virol; 2015 Aug; 89(15):7612-24. PubMed ID: 25972552
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structural variability of the carboxy-terminus of Epstein-Barr virus encoded latent membrane protein 1 gene in Hodgkin's lymphomas.
    Guiretti DM; Chabay PA; Valva P; Stefanoff CG; Barros MH; De Matteo E; Renault IZ; Preciado MV; Hassan R
    J Med Virol; 2007 Nov; 79(11):1730-22. PubMed ID: 17854036
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Deletion of Epstein-Barr virus latent membrane protein 1 gene in Japanese and Brazilian gastric carcinomas, metastatic lesions, and reactive lymphocytes.
    Hayashi K; Chen WG; Chen YY; Murakami I; Chen HL; Ohara N; Nose S; Hamaya K; Matsui S; Bacchi MM; Bacchi CE; Chang KL; Weiss LM
    Am J Pathol; 1998 Jan; 152(1):191-8. PubMed ID: 9422536
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Selective outgrowth of a posttransplant B-immunoblastic lymphoma expressing a latent membrane protein-1 deletion variant.
    Kershaw GR; Berger C; McQuain C; al-Homsi AS; Pihan G; Quesenberry PJ; Woda BA; Knecht H
    Transplantation; 1997 Oct; 64(7):1079-81. PubMed ID: 9381534
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epstein-Barr virus gene expression in the peripheral blood of transplant recipients with persistent circulating virus loads.
    Qu L; Green M; Webber S; Reyes J; Ellis D; Rowe D
    J Infect Dis; 2000 Oct; 182(4):1013-21. PubMed ID: 10979894
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mutational hot spots within the carboxy terminal region of the LMP1 oncogene of Epstein-Barr virus are frequent in lymphoproliferative disorders.
    Knecht H; Bachmann E; Brousset P; Rothenberger S; Einsele H; Lestou VS; Delsol G; Bachmann F; Ambros PF; Odermatt BF
    Oncogene; 1995 Feb; 10(3):523-8. PubMed ID: 7845677
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular epidemiology of deletions and mutations of the latent membrane protein 1 oncogene of the Epstein-Barr virus in posttransplant lymphoproliferative disorders.
    Smir BN; Hauke RJ; Bierman PJ; Gross TG; d'Amore F; Anderson JR; Greiner TC
    Lab Invest; 1996 Oct; 75(4):575-88. PubMed ID: 8874388
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.